Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Specialized Health Products SHPI -- Ignore unavailable to you. Want to Upgrade?

To: Power of 0 who wrote (6)	3/29/1999 9:37:00 AM
From: Bryan C. Simpson	Respond to of 17

I've talked with a few employees and I guess they have now hired their third PR firm. They are also late with their first product, but are planning for early summer. At least one employee is confident enough to have purchased SHPI in their self directed 401k. Bryan

To: Power of 0 who wrote (6)	5/21/1999 12:08:00 PM
From: Bryan C. Simpson	Respond to of 17

VERNON, Conn.--(BW HealthWire)Thursday May 20, 11:11 am Eastern Time Company Press Release Federal Safety Needle Legislation VERNON, Conn.--(BW HealthWire)--May 20, 1999--The momentum toward mandating safe needles to protect health care workers continues to grow. Today in Washington, D.C., Representative Pete Stark (D-California) and Representative Marge Roukema (R-NJ) introduced a bill in Congress mandating the use safe needles for healthcare workers. The proposed legislation mirrors the 1998 California law requiring that hospitals use needles designed with 'engineered controls' to protect the workers from accidental needlesticks. ''Mandating the use of safe needles on a national level will have a tremendous impact in preventing accidental needlesticks,'' said Tom Sutton, Executive Vice President at Bio-Plexus, Inc. According to Congressman Stark's office, needlestick injuries caused by hollow-bore needles account for 86% of all reported occupational HIV exposures, and every year more than 200 health care workers die of occupationally acquired hepatitis. ''If safety needles are nationally mandated, as it appears they may be, conventional, 'unsafe' needles will become obsolete,'' Sutton concluded. In addition to being endorsed by Bio-Plexus, the act is also supported by organizations including: the American Nurses Association, Kaiser Permanente, the American Federation of State, County and Municipal Employees, the Service Employees International Union, the American Federation of Teachers, and Becton Dickinson, a major medical device manufacturer. On the state level, legislation mandating the use of safety needles has passed in California and Tennessee. In April, Maryland passed a bill requiring the state to develop recommendations to protect health care workers. Legislation is pending in Texas, New Jersey, Arkansas, Connecticut, Massachusetts, Michigan, and New York. Bio-Plexus, Inc. (NASDAQ:BPLX - news), designs, develops, manufactures, markets, and holds U.S. and international patents on safety medical needles and other products under the PUNCTUR-GUARD® and DROP-IT® brand names. In a Centers for Disease Control study, Punctur-Guard Blood Collection Needles were found to reduce the rate of accidental needlesticks among healthcare workers by 76%, the highest rate of any device studied. Accidental needlesticks number about one million per year in the United States and can result in the transmission of deadly diseases including HIV and Hepatitis. NOTE: THIS PRESS RELEASE MAY CONTAIN FORWARD-LOOKING STATEMENTS WHICH ARE SUBJECT TO RISKS AND UNCERTAINTIES. THE ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE DESCRIBED IN ANY SUCH FORWARD-LOOKING STATEMENT AS A RESULT OF FACTORS DESCRIBED FROM TIME TO TIME IN THE COMPANY'S PERIODIC REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION OR DISCUSSED IN OTHER PRESS RELEASES ISSUED BY THE COMPANY.

To: Power of 0 who wrote (6)	6/9/1999 12:44:00 PM
From: Bryan C. Simpson	Read Replies (1) \| Respond to of 17

Specialized Health Products International, Inc. Announces Amendment to Agreement With Becton Dickinson BOUNTIFUL, Utah--(BW HealthWire)--June 9, 1999--Specialized Health Products International, Inc. (NASDAQ: SHPI - news) today announced its wholly-owned subsidiary, Specialized Health Products, Inc. (''SHP''), signed an amendment to its worldwide License Agreement with Becton, Dickinson and Company (''BD'')(NYSE: BDX - news). This Amendment provides that the $3.75 million previously paid by BD to SHP, will not be credited against future earned product royalties and SHP will have no further obligation to BD with respect to these payments. As part of this Amendment, SHP has agreed to defer BD exclusivity related minimum royalty obligations from 2002 to 2004. All other obligations under the Agreement remain in full force and effect. David A. Robinson, President and CEO of SHPI said, ''This amendment enables SHPI to recognize the full $3.75 million as revenue immediately which will put SHPI in a position to exceed the minimum Nasdaq SmallCap net tangible asset listing requirement. This revenue should also enable the Company to realize its first year of profitability. Although we have significant challenges ahead, my view of the potential success of SHPI has never been brighter because of the positive momentum of the new safety legislation, and current expressed interest in SHP's safety needle product lines by major medical product companies.'' SHPI's patented safety technologies are applicable to a variety of fields of safety products, including lancets, phlebotomy devices, catheters, syringes and butterflies. Additional products will augment the SHPI product line in the future. SHP now owns seven Safety Cradle® related patents, two patents associated with its ExtreSafe® Lancets and ten granted patents which protect its ExtreSafe® and FlexLoc(TM) safety needle technologies. SHP has additional patents pending. ----------- This is money, but I wonder if this has to do with BDX working with MEDC now???? At least there has been some upward movement Bryan